{
    "data": [
        {
            "id": 2569319,
            "title": "Motorola Solutions: Strong Financial Outlook and Growth Prospects Justify Buy Rating",
            "description": "<p></p>\n<p>Andrew Spinola has given his Buy rating due to a combination of factors including Motorola Solutions’ solid financial outlook and performance. The company reported Q3 revenue slightly above expectations at $3.01 billion, driven by strong performance from Silvus, which is expected to continue its growth trajectory and contribute significantly to future earnings. The F26 revenue outlook of $12.6 billion, up 8% year-over-year, was a positive surprise, alleviating concerns about meeting consensus estimates.<br>Moreover, the company’s backlog has increased, indicating strong demand, and there is notable growth in their SVX and APX Next applications. These factors, along with a reiterated F25 guidance and an unchanged price target of $510, underpin Spinola’s confidence in the company’s continued growth and justify the Buy rating.</p>\n<p>In another report released today, Barclays also maintained a Buy rating on the stock with a $495.00 price target.</p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_1820093804-750x406.jpg",
            "link": "https://www.tipranks.com/news/ratings/motorola-solutions-strong-financial-outlook-and-growth-prospects-justify-buy-rating-ratings",
            "author": "TipRanks Auto-Generated Intelligence Newsdesk",
            "pub_date": "2025-10-31 19:15:45",
            "source": "tipranks_others",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2569223,
            "title": "RBC Capital Reaffirms Their Buy Rating on Mastercard (MA)",
            "description": "<p></p>\n<p>According to <a href=\"https://www.tipranks.com\" target=\"_blank\" style=\"color:blue\">TipRanks</a>, Perlin is an analyst with an average return of <span style=\"color:red;font-weight:bold;\">-11.0%</span> and a 35.81% success rate. Perlin covers the Technology sector, focusing on stocks such as Jack Henry &amp; Associates, NCR Voyix, and Affirm Holdings.</p>\n<p>In addition to RBC Capital, Mastercard also received a Buy from Wells Fargo’s Jason Kupferberg in a report issued today. However, on October 27, Monness reiterated a Hold rating on Mastercard (NYSE: MA).</p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_1216127341-750x406.jpg",
            "link": "https://www.tipranks.com/news/blurbs/rbc-capital-reaffirms-their-buy-rating-on-mastercard-ma-blurbs",
            "author": "TipRanks Auto-Generated Intelligence Newsdesk",
            "pub_date": "2025-10-31 19:01:44",
            "source": "tipranks_others",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2569224,
            "title": "RBC Capital Sticks to Its Buy Rating for Stryker (SYK)",
            "description": "<p></p>\n<p>Singh Chadha covers the Healthcare sector, focusing on stocks such as Edwards Lifesciences, Becton Dickinson, and Boston Scientific. According to <a href=\"https://www.tipranks.com\" target=\"_blank\" style=\"color:blue\">TipRanks</a>, Singh Chadha has an average return of <span style=\"color:red;font-weight:bold;\">-0.9%</span> and a 48.02% success rate on recommended stocks. </p>\n<p>The word on The Street in general, suggests a Strong Buy analyst consensus rating for Stryker with a $436.56 average price target, a 18.32% upside from current levels. In a report released today, Barclays also maintained a Buy rating on the stock with a $453.00 price target.</p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_1423187486-750x406.jpg",
            "link": "https://www.tipranks.com/news/blurbs/rbc-capital-sticks-to-its-buy-rating-for-stryker-syk-blurbs",
            "author": "TipRanks Auto-Generated Intelligence Newsdesk",
            "pub_date": "2025-10-31 19:01:47",
            "source": "tipranks_others",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2569225,
            "title": "RBC Capital Keeps Their Hold Rating on Vulcan Materials (VMC)",
            "description": "<p></p>\n<p>Codling covers the Consumer Cyclical sector, focusing on stocks such as Barratt Redrow, Bellway, and Vistry Group. According to <a href=\"https://www.tipranks.com\" target=\"_blank\" style=\"color:blue\">TipRanks</a>, Codling has an average return of <span style=\"color:green;font-weight:bold;\">8.1%</span> and a 60.56% success rate on recommended stocks. </p>\n<p>Currently, the analyst consensus on Vulcan Materials is a Strong Buy with an average price target of $323.08.</p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_1740531587-2-750x406.jpg",
            "link": "https://www.tipranks.com/news/blurbs/rbc-capital-keeps-their-hold-rating-on-vulcan-materials-vmc-blurbs-2",
            "author": "TipRanks Auto-Generated Intelligence Newsdesk",
            "pub_date": "2025-10-31 19:01:51",
            "source": "tipranks_others",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2569226,
            "title": "RBC Capital Keeps Their Buy Rating on Ametek (AME)",
            "description": "<p></p>\n<p>According to <a href=\"https://www.tipranks.com\" target=\"_blank\" style=\"color:blue\">TipRanks</a>, Dray is a 5-star analyst with an average return of <span style=\"color:green;font-weight:bold;\">13.9%</span> and a 62.32% success rate. Dray covers the Industrials sector, focusing on stocks such as Carrier Global, Eaton, and Trane Technologies.</p>\n<p>In addition to RBC Capital, Ametek also received a Buy from TR | OpenAI – 4o’s Garrick Presswyn  in a report issued yesterday. However, today, Barclays maintained a Hold rating on Ametek (NYSE: AME).</p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2022/10/shutterstock_1371862175.jpg",
            "link": "https://www.tipranks.com/news/blurbs/rbc-capital-keeps-their-buy-rating-on-ametek-ame-blurbs",
            "author": "TipRanks Auto-Generated Intelligence Newsdesk",
            "pub_date": "2025-10-31 19:01:54",
            "source": "tipranks_others",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2569227,
            "title": "RBC Capital Reaffirms Their Hold Rating on Builders Firstsource (BLDR)",
            "description": "<p></p>\n<p>According to <a href=\"https://www.tipranks.com\" target=\"_blank\" style=\"color:blue\">TipRanks</a>, Dahl is a 5-star analyst with an average return of <span style=\"color:green;font-weight:bold;\">8.9%</span> and a 59.47% success rate. Dahl covers the Consumer Cyclical sector, focusing on stocks such as DR Horton, KB Home, and Lennar.</p>\n<p>The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Builders Firstsource with a $136.46 average price target, a 22.18% upside from current levels. In a report released today, Bank of America Securities also reiterated a Hold rating on the stock with a $123.00 price target.</p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2023/06/Industrials-1-750x406.jpg",
            "link": "https://www.tipranks.com/news/blurbs/rbc-capital-reaffirms-their-hold-rating-on-builders-firstsource-bldr-blurbs",
            "author": "TipRanks Auto-Generated Intelligence Newsdesk",
            "pub_date": "2025-10-31 19:01:57",
            "source": "tipranks_others",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2569228,
            "title": "RBC Capital Sticks to Its Buy Rating for Dexcom (DXCM)",
            "description": "<p></p>\n<p>According to <a href=\"https://www.tipranks.com\" target=\"_blank\" style=\"color:blue\">TipRanks</a>, Singh Chadha is an analyst with an average return of <span style=\"color:red;font-weight:bold;\">-0.9%</span> and a 48.02% success rate. Singh Chadha covers the Healthcare sector, focusing on stocks such as Edwards Lifesciences, Becton Dickinson, and Boston Scientific.</p>\n<p>Currently, the analyst consensus on Dexcom is a Strong Buy with an average price target of $92.20, representing a 35.19% upside. In a report released today, Wells Fargo also maintained a Buy rating on the stock with a $93.00 price target.</p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_1096459574-750x406.jpg",
            "link": "https://www.tipranks.com/news/blurbs/rbc-capital-sticks-to-its-buy-rating-for-dexcom-dxcm-blurbs",
            "author": "TipRanks Auto-Generated Intelligence Newsdesk",
            "pub_date": "2025-10-31 19:02:01",
            "source": "tipranks_others",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2569229,
            "title": "RBC Capital Keeps Their Buy Rating on Agios Pharma (AGIO)",
            "description": "<p></p>\n<p>Issi covers the Healthcare sector, focusing on stocks such as Ascendis Pharma, BioMarin Pharmaceutical, and Ionis Pharmaceuticals. According to <a href=\"https://www.tipranks.com\" target=\"_blank\" style=\"color:blue\">TipRanks</a>, Issi has an average return of <span style=\"color:green;font-weight:bold;\">6.7%</span> and a 41.16% success rate on recommended stocks. </p>\n<p>In addition to RBC Capital, Agios Pharma also received a Buy from TD Cowen’s Marc Frahm in a report issued yesterday. However, on October 22, TR | OpenAI – 4o reiterated a Hold rating on Agios Pharma (NASDAQ: AGIO).</p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_1911898180-750x406.jpg",
            "link": "https://www.tipranks.com/news/blurbs/rbc-capital-keeps-their-buy-rating-on-agios-pharma-agio-blurbs",
            "author": "TipRanks Auto-Generated Intelligence Newsdesk",
            "pub_date": "2025-10-31 19:02:04",
            "source": "tipranks_others",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2569230,
            "title": "RBC Capital Sticks to Their Hold Rating for DXC Technology (DXC)",
            "description": "<p></p>\n<p>Perlin covers the Technology sector, focusing on stocks such as Jack Henry &amp; Associates, NCR Voyix, and Affirm Holdings. According to <a href=\"https://www.tipranks.com\" target=\"_blank\" style=\"color:blue\">TipRanks</a>, Perlin has an average return of <span style=\"color:red;font-weight:bold;\">-11.0%</span> and a 35.81% success rate on recommended stocks. </p>\n<p>The word on The Street in general, suggests a Hold analyst consensus rating for DXC Technology with a $15.17 average price target, implying a 17.23% upside from current levels. In a report released yesterday, TD Cowen also maintained a Hold rating on the stock with a $15.00 price target.</p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_112821256-750x406.jpg",
            "link": "https://www.tipranks.com/news/blurbs/rbc-capital-sticks-to-their-hold-rating-for-dxc-technology-dxc-blurbs",
            "author": "TipRanks Auto-Generated Intelligence Newsdesk",
            "pub_date": "2025-10-31 19:02:07",
            "source": "tipranks_others",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2569238,
            "title": "UBS Sticks to Its Buy Rating for Zabka Group (ZAB)",
            "description": "<p></p>\n<p>According to <a href=\"https://www.tipranks.com\" target=\"_blank\" style=\"color:blue\">TipRanks</a>, Potyra is ranked #8351 out of 10072 analysts.</p>\n<p>Currently, the analyst consensus on Zabka Group is a Moderate Buy with an average price target of PLN27.50.</p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_2110920059-1-750x406.jpg",
            "link": "https://www.tipranks.com/news/blurbs/ubs-sticks-to-its-buy-rating-for-zabka-group-zab-blurbs",
            "author": "TipRanks Auto-Generated Intelligence Newsdesk",
            "pub_date": "2025-10-31 19:05:21",
            "source": "tipranks_others",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2569239,
            "title": "Morgan Stanley Reaffirms Their Buy Rating on Cigna (CI)",
            "description": "<p></p>\n<p>According to <a href=\"https://www.tipranks.com\" target=\"_blank\" style=\"color:blue\">TipRanks</a>, Wright is a 5-star analyst with an average return of <span style=\"color:green;font-weight:bold;\">14.4%</span> and a 64.90% success rate. Wright covers the Healthcare sector, focusing on stocks such as CVS Health, BrightSpring Health Services, Inc., and UnitedHealth.</p>\n<p>In addition to Morgan Stanley, Cigna also received a Buy from Bank of America Securities’s Kevin Fischbeck in a report issued today. However, on October 16, Bernstein maintained a Hold rating on Cigna (NYSE: CI).</p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_2162340203-750x406.jpg",
            "link": "https://www.tipranks.com/news/blurbs/morgan-stanley-reaffirms-their-buy-rating-on-cigna-ci-blurbs",
            "author": "TipRanks Auto-Generated Intelligence Newsdesk",
            "pub_date": "2025-10-31 19:05:24",
            "source": "tipranks_others",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2569241,
            "title": "UBS Reaffirms Their Buy Rating on Twilio (TWLO)",
            "description": "<p></p>\n<p>McGinnis covers the Technology sector, focusing on stocks such as Autodesk, Intuit, and HubSpot. According to <a href=\"https://www.tipranks.com\" target=\"_blank\" style=\"color:blue\">TipRanks</a>, McGinnis has an average return of <span style=\"color:red;font-weight:bold;\">-13.7%</span> and a 32.32% success rate on recommended stocks. </p>\n<p>In addition to UBS, Twilio also received a Buy from Wells Fargo’s Ryan MacWilliams in a report issued today. However, on the same day, Bank of America Securities reiterated a Sell rating on Twilio (NYSE: TWLO).</p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_2153315777-750x406.jpg",
            "link": "https://www.tipranks.com/news/blurbs/ubs-reaffirms-their-buy-rating-on-twilio-twlo-blurbs",
            "author": "TipRanks Auto-Generated Intelligence Newsdesk",
            "pub_date": "2025-10-31 19:05:27",
            "source": "tipranks_others",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2569242,
            "title": "Crocs (CROX) Gets a Hold from UBS",
            "description": "<p></p>\n<p>According to <a href=\"https://www.tipranks.com\" target=\"_blank\" style=\"color:blue\">TipRanks</a>, Sole is a 4-star analyst with an average return of <span style=\"color:green;font-weight:bold;\">4.4%</span> and a 48.88% success rate. Sole covers the Consumer Cyclical sector, focusing on stocks such as On Holding AG, Crocs, and Deckers Outdoor.</p>\n<p>In addition to UBS, Crocs also received a Hold from Barclays’s Adrienne Yih in a report issued today. However, on the same day, KeyBanc maintained a Buy rating on Crocs (NASDAQ: CROX).</p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2023/06/Consumer-Cylical-9-750x406.jpg",
            "link": "https://www.tipranks.com/news/blurbs/crocs-crox-gets-a-hold-from-ubs-blurbs",
            "author": "TipRanks Auto-Generated Intelligence Newsdesk",
            "pub_date": "2025-10-31 19:05:31",
            "source": "tipranks_others",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2569172,
            "title": "RBC Capital Sticks to Its Buy Rating for Howmet Aerospace (HWM)",
            "description": "<p></p>\n<p>According to <a href=\"https://www.tipranks.com\" target=\"_blank\" style=\"color:blue\">TipRanks</a>, Herbert is a top 100 analyst with an average return of <span style=\"color:green;font-weight:bold;\">24.2%</span> and a 69.86% success rate. Herbert covers the Industrials sector, focusing on stocks such as Airbus Group SE, Boeing, and AeroVironment.</p>\n<p>Currently, the analyst consensus on Howmet Aerospace is a Strong Buy with an average price target of $212.80, a 5.47% upside from current levels. In a report released yesterday, TD Cowen also maintained a Buy rating on the stock with a $240.00 price target.</p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2023/06/Industrials-2-750x406.jpg",
            "link": "https://www.tipranks.com/news/blurbs/rbc-capital-sticks-to-its-buy-rating-for-howmet-aerospace-hwm-blurbs",
            "author": "TipRanks Auto-Generated Intelligence Newsdesk",
            "pub_date": "2025-10-31 18:59:05",
            "source": "tipranks_others",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2569173,
            "title": "RBC Capital Keeps Their Buy Rating on Independence Realty (IRT)",
            "description": "<p></p>\n<p>According to <a href=\"https://www.tipranks.com\" target=\"_blank\" style=\"color:blue\">TipRanks</a>, Heffern is ranked #1657 out of 10072 analysts.</p>\n<p>Currently, the analyst consensus on Independence Realty is a Moderate Buy with an average price target of $20.65, implying a 30.94% upside from current levels. In a report released today, Citizens JMP also reiterated a Buy rating on the stock with a $25.00 price target.</p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2023/06/shutterstock_1347656177-750x406.jpg",
            "link": "https://www.tipranks.com/news/blurbs/rbc-capital-keeps-their-buy-rating-on-independence-realty-irt-blurbs",
            "author": "TipRanks Auto-Generated Intelligence Newsdesk",
            "pub_date": "2025-10-31 18:59:08",
            "source": "tipranks_others",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2569174,
            "title": "Ingram Micro Holding Corporation (INGM) Receives a Buy from RBC Capital",
            "description": "<p></p>\n<p>According to <a href=\"https://www.tipranks.com\" target=\"_blank\" style=\"color:blue\">TipRanks</a>, Paige is ranked #3404 out of 10072 analysts.</p>\n<p>Ingram Micro Holding Corporation has an analyst consensus of Moderate Buy, with a price target consensus of $23.83.</p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_1975936445-750x406.jpg",
            "link": "https://www.tipranks.com/news/blurbs/ingram-micro-holding-corporation-ingm-receives-a-buy-from-rbc-capital-blurbs-2",
            "author": "TipRanks Auto-Generated Intelligence Newsdesk",
            "pub_date": "2025-10-31 18:59:10",
            "source": "tipranks_others",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2569175,
            "title": "Insmed (INSM) Gets a Buy from RBC Capital",
            "description": "<p></p>\n<p>Timashev covers the Healthcare sector, focusing on stocks such as Alkermes, Insmed, and IDEAYA Biosciences. According to <a href=\"https://www.tipranks.com\" target=\"_blank\" style=\"color:blue\">TipRanks</a>, Timashev has an average return of <span style=\"color:green;font-weight:bold;\">28.0%</span> and a 60.34% success rate on recommended stocks. </p>\n<p>The word on The Street in general, suggests a Strong Buy analyst consensus rating for Insmed with a $184.00 average price target, a -5.26% downside from current levels. In a report released today, Wells Fargo also maintained a Buy rating on the stock with a $217.00 price target.</p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_1110645284-750x406.jpg",
            "link": "https://www.tipranks.com/news/blurbs/insmed-insm-gets-a-buy-from-rbc-capital-blurbs",
            "author": "TipRanks Auto-Generated Intelligence Newsdesk",
            "pub_date": "2025-10-31 18:59:13",
            "source": "tipranks_others",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2569176,
            "title": "RBC Capital Sticks to Its Buy Rating for Intercontinental Exchange (ICE)",
            "description": "<p></p>\n<p>Sabadra covers the Financial sector, focusing on stocks such as Cboe Global Markets, CME Group, and Intercontinental Exchange. According to <a href=\"https://www.tipranks.com\" target=\"_blank\" style=\"color:blue\">TipRanks</a>, Sabadra has an average return of <span style=\"color:green;font-weight:bold;\">4.7%</span> and a 56.53% success rate on recommended stocks. </p>\n<p>The word on The Street in general, suggests a Strong Buy analyst consensus rating for Intercontinental Exchange with a $201.11 average price target, representing a 35.41% upside. In a report released today, Barclays also maintained a Buy rating on the stock with a $183.00 price target.</p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_2092362163-750x406.jpg",
            "link": "https://www.tipranks.com/news/blurbs/rbc-capital-sticks-to-its-buy-rating-for-intercontinental-exchange-ice-blurbs-3",
            "author": "TipRanks Auto-Generated Intelligence Newsdesk",
            "pub_date": "2025-10-31 18:59:17",
            "source": "tipranks_others",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2569178,
            "title": "RBC Capital Sticks to Its Buy Rating for International Paper Co (IP)",
            "description": "<p></p>\n<p>McKellar covers the Basic Materials sector, focusing on stocks such as Interfor, Clearwater Paper, and Mercer International. According to <a href=\"https://www.tipranks.com\" target=\"_blank\" style=\"color:blue\">TipRanks</a>, McKellar has an average return of <span style=\"color:red;font-weight:bold;\">-1.1%</span> and a 34.38% success rate on recommended stocks. </p>\n<p>In addition to RBC Capital, International Paper Co also received a Buy from Truist Financial’s Michael Roxland in a report issued on October 20. However, today, Wells Fargo maintained a Sell rating on International Paper Co (NYSE: IP).</p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2023/06/Consumer-Cylical-5-750x406.jpg",
            "link": "https://www.tipranks.com/news/blurbs/rbc-capital-sticks-to-its-buy-rating-for-international-paper-co-ip-blurbs-2",
            "author": "TipRanks Auto-Generated Intelligence Newsdesk",
            "pub_date": "2025-10-31 18:59:19",
            "source": "tipranks_others",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2569179,
            "title": "RBC Capital Reaffirms Their Hold Rating on Invitation Homes (INVH)",
            "description": "<p></p>\n<p>According to <a href=\"https://www.tipranks.com\" target=\"_blank\" style=\"color:blue\">TipRanks</a>, Heffern is a 4-star analyst with an average return of <span style=\"color:green;font-weight:bold;\">7.3%</span> and a 44.15% success rate.</p>\n<p>In addition to RBC Capital, Invitation Homes also received a Hold from BMO Capital’s Juan C. Sanabria in a report issued yesterday. However, on October 21, Mizuho Securities maintained a Buy rating on Invitation Homes (NYSE: INVH).</p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2023/06/shutterstock_261540053-750x406.jpg",
            "link": "https://www.tipranks.com/news/blurbs/rbc-capital-reaffirms-their-hold-rating-on-invitation-homes-invh-blurbs",
            "author": "TipRanks Auto-Generated Intelligence Newsdesk",
            "pub_date": "2025-10-31 18:59:22",
            "source": "tipranks_others",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2569181,
            "title": "L3Harris Technologies (LHX) Receives a Rating Update from a Top Analyst",
            "description": "<p></p>\n<p>Herbert covers the Industrials sector, focusing on stocks such as Airbus Group SE, Boeing, and AeroVironment. According to <a href=\"https://www.tipranks.com\" target=\"_blank\" style=\"color:blue\">TipRanks</a>, Herbert has an average return of <span style=\"color:green;font-weight:bold;\">24.2%</span> and a 69.86% success rate on recommended stocks. </p>\n<p>Currently, the analyst consensus on L3Harris Technologies is a Moderate Buy with an average price target of $323.40, implying a 9.29% upside from current levels. In a report released on October 15, Morgan Stanley also maintained a Hold rating on the stock with a $350.00 price target.</p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2023/06/Industrials-6-750x406.jpg",
            "link": "https://www.tipranks.com/news/blurbs/l3harris-technologies-lhx-receives-a-rating-update-from-a-top-analyst-blurbs-5",
            "author": "TipRanks Auto-Generated Intelligence Newsdesk",
            "pub_date": "2025-10-31 18:59:25",
            "source": "tipranks_others",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2569183,
            "title": "Mid-America Apartment (MAA) Receives a Hold from RBC Capital",
            "description": "<p></p>\n<p>According to <a href=\"https://www.tipranks.com\" target=\"_blank\" style=\"color:blue\">TipRanks</a>, Heffern is a 4-star analyst with an average return of <span style=\"color:green;font-weight:bold;\">7.3%</span> and a 44.15% success rate.</p>\n<p>Currently, the analyst consensus on Mid-America Apartment is a Moderate Buy with an average price target of $155.88, a 21.02% upside from current levels. In a report released yesterday, Piper Sandler also maintained a Hold rating on the stock with a $153.00 price target.</p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2023/06/shutterstock_1030918024-750x406.jpg",
            "link": "https://www.tipranks.com/news/blurbs/mid-america-apartment-maa-receives-a-hold-from-rbc-capital-blurbs-3",
            "author": "TipRanks Auto-Generated Intelligence Newsdesk",
            "pub_date": "2025-10-31 18:59:28",
            "source": "tipranks_others",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2569184,
            "title": "RBC Capital Sticks to Their Hold Rating for Public Storage (PSA)",
            "description": "<p></p>\n<p>According to <a href=\"https://www.tipranks.com\" target=\"_blank\" style=\"color:blue\">TipRanks</a>, Heffern is a 4-star analyst with an average return of <span style=\"color:green;font-weight:bold;\">7.3%</span> and a 44.15% success rate.</p>\n<p>Currently, the analyst consensus on Public Storage is a Moderate Buy with an average price target of $322.53, a 14.84% upside from current levels. In a report released yesterday, Evercore ISI also maintained a Hold rating on the stock with a $317.00 price target.</p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2023/06/shutterstock_2021530538-750x406.jpg",
            "link": "https://www.tipranks.com/news/blurbs/rbc-capital-sticks-to-their-hold-rating-for-public-storage-psa-blurbs",
            "author": "TipRanks Auto-Generated Intelligence Newsdesk",
            "pub_date": "2025-10-31 18:59:31",
            "source": "tipranks_others",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2569185,
            "title": "RBC Capital Keeps Their Hold Rating on Reddit Inc Class A (RDDT)",
            "description": "<p></p>\n<p>According to <a href=\"https://www.tipranks.com\" target=\"_blank\" style=\"color:blue\">TipRanks</a>, Erickson is a 5-star analyst with an average return of <span style=\"color:green;font-weight:bold;\">21.6%</span> and a 56.12% success rate. Erickson covers the Communication Services sector, focusing on stocks such as Reddit Inc Class A, Zillow Group Class A, and Alphabet Class A.</p>\n<p>In addition to RBC Capital, Reddit Inc Class A also received a Hold from Bank of America Securities’s Justin Post in a report issued today. However, on the same day, Citizens JMP reiterated a Buy rating on Reddit Inc Class A (NYSE: RDDT).</p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2023/06/Communication-Services-3-750x406.jpg",
            "link": "https://www.tipranks.com/news/blurbs/rbc-capital-keeps-their-hold-rating-on-reddit-inc-class-a-rddt-blurbs-2",
            "author": "TipRanks Auto-Generated Intelligence Newsdesk",
            "pub_date": "2025-10-31 18:59:34",
            "source": "tipranks_others",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2569186,
            "title": "RBC Capital Sticks to Its Buy Rating for Resmed (RMD)",
            "description": "<p></p>\n<p>According to <a href=\"https://www.tipranks.com\" target=\"_blank\" style=\"color:blue\">TipRanks</a>, Wong-Pan is an analyst with an average return of <span style=\"color:red;font-weight:bold;\">-1.1%</span> and a 48.54% success rate. Wong-Pan covers the Healthcare sector, focusing on stocks such as Regis Healthcare Ltd., Resmed, and CSL.</p>\n<p>Currently, the analyst consensus on Resmed is a Moderate Buy with an average price target of $301.36.</p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_1549769756-750x406.jpg",
            "link": "https://www.tipranks.com/news/blurbs/rbc-capital-sticks-to-its-buy-rating-for-resmed-rmd-blurbs",
            "author": "TipRanks Auto-Generated Intelligence Newsdesk",
            "pub_date": "2025-10-31 18:59:37",
            "source": "tipranks_others",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2569187,
            "title": "RBC Capital Remains a Hold on Rocket Companies (RKT)",
            "description": "<p></p>\n<p>Perlin covers the Technology sector, focusing on stocks such as Jack Henry &amp; Associates, NCR Voyix, and Affirm Holdings. According to <a href=\"https://www.tipranks.com\" target=\"_blank\" style=\"color:blue\">TipRanks</a>, Perlin has an average return of <span style=\"color:red;font-weight:bold;\">-11.0%</span> and a 35.81% success rate on recommended stocks. </p>\n<p>Currently, the analyst consensus on Rocket Companies is a Hold with an average price target of $13.83, implying a -13.24% downside from current levels. In a report released today, Barclays also maintained a Hold rating on the stock with a $19.00 price target.</p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_574713295-2-750x406.jpg",
            "link": "https://www.tipranks.com/news/blurbs/rbc-capital-remains-a-hold-on-rocket-companies-rkt-blurbs",
            "author": "TipRanks Auto-Generated Intelligence Newsdesk",
            "pub_date": "2025-10-31 18:59:40",
            "source": "tipranks_others",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2569189,
            "title": "S&P Global (SPGI) Gets a Buy from RBC Capital",
            "description": "<p></p>\n<p>Sabadra covers the Financial sector, focusing on stocks such as Cboe Global Markets, CME Group, and Intercontinental Exchange. According to <a href=\"https://www.tipranks.com\" target=\"_blank\" style=\"color:blue\">TipRanks</a>, Sabadra has an average return of <span style=\"color:green;font-weight:bold;\">4.7%</span> and a 56.53% success rate on recommended stocks. </p>\n<p>S&amp;P Global has an analyst consensus of Strong Buy, with a price target consensus of $613.71, a 24.85% upside from current levels. In a report released today, Barclays also maintained a Buy rating on the stock with a $620.00 price target.</p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_574713295-2-750x406.jpg",
            "link": "https://www.tipranks.com/news/blurbs/sp-global-spgi-gets-a-buy-from-rbc-capital-blurbs-2",
            "author": "TipRanks Auto-Generated Intelligence Newsdesk",
            "pub_date": "2025-10-31 18:59:43",
            "source": "tipranks_others",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2569190,
            "title": "RBC Capital Sticks to Its Hold Rating for Thryv Holdings (THRY)",
            "description": "<p></p>\n<p>Swanson covers the Technology sector, focusing on stocks such as Adobe, International Business Machines, and PubMatic. According to <a href=\"https://www.tipranks.com\" target=\"_blank\" style=\"color:blue\">TipRanks</a>, Swanson has an average return of <span style=\"color:red;font-weight:bold;\">-3.8%</span> and a 39.89% success rate on recommended stocks. </p>\n<p>Thryv Holdings has an analyst consensus of Strong Buy, with a price target consensus of $13.50, a 65.24% upside from current levels. In a report released yesterday, TR | OpenAI – 4o also reiterated a Hold rating on the stock with a $12.00 price target.</p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2023/06/Communication-Services-8-750x406.jpg",
            "link": "https://www.tipranks.com/news/blurbs/rbc-capital-sticks-to-its-hold-rating-for-thryv-holdings-thry-blurbs",
            "author": "TipRanks Auto-Generated Intelligence Newsdesk",
            "pub_date": "2025-10-31 18:59:45",
            "source": "tipranks_others",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2569191,
            "title": "RBC Capital Remains a Hold on Trane Technologies (TT)",
            "description": "<p></p>\n<p>According to <a href=\"https://www.tipranks.com\" target=\"_blank\" style=\"color:blue\">TipRanks</a>, Dray is a 5-star analyst with an average return of <span style=\"color:green;font-weight:bold;\">13.9%</span> and a 62.32% success rate. Dray covers the Industrials sector, focusing on stocks such as Carrier Global, Eaton, and Trane Technologies.</p>\n<p>In addition to RBC Capital, Trane Technologies also received a Hold from KeyBanc’s Jeffrey Hammond in a report issued today. However, on the same day, Barclays maintained a Buy rating on Trane Technologies (NYSE: TT).</p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2023/06/Industrials-8-750x406.jpg",
            "link": "https://www.tipranks.com/news/blurbs/rbc-capital-remains-a-hold-on-trane-technologies-tt-blurbs",
            "author": "TipRanks Auto-Generated Intelligence Newsdesk",
            "pub_date": "2025-10-31 18:59:48",
            "source": "tipranks_others",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2569192,
            "title": "RBC Capital Sticks to Its Sell Rating for Twilio (TWLO)",
            "description": "<p></p>\n<p>Jaluria covers the Technology sector, focusing on stocks such as MongoDB, Clearwater Analytics Holdings, and Intuit. According to <a href=\"https://www.tipranks.com\" target=\"_blank\" style=\"color:blue\">TipRanks</a>, Jaluria has an average return of <span style=\"color:red;font-weight:bold;\">-4.5%</span> and a 51.40% success rate on recommended stocks. </p>\n<p>In addition to RBC Capital, Twilio also received a Sell from Bank of America Securities’s Koji Ikeda in a report issued today. However, on the same day, Citizens JMP maintained a Buy rating on Twilio (NYSE: TWLO).</p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_1939250359-750x406.jpg",
            "link": "https://www.tipranks.com/news/blurbs/rbc-capital-sticks-to-its-sell-rating-for-twilio-twlo-blurbs",
            "author": "TipRanks Auto-Generated Intelligence Newsdesk",
            "pub_date": "2025-10-31 18:59:51",
            "source": "tipranks_others",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2569193,
            "title": "RBC Capital Remains a Hold on Wesco International (WCC)",
            "description": "<p></p>\n<p>According to <a href=\"https://www.tipranks.com\" target=\"_blank\" style=\"color:blue\">TipRanks</a>, Dray is a 5-star analyst with an average return of <span style=\"color:green;font-weight:bold;\">13.9%</span> and a 62.32% success rate. Dray covers the Industrials sector, focusing on stocks such as Carrier Global, Eaton, and Trane Technologies.</p>\n<p>Currently, the analyst consensus on Wesco International is a Strong Buy with an average price target of $251.63.</p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2023/06/Industrials-4-750x406.jpg",
            "link": "https://www.tipranks.com/news/blurbs/rbc-capital-remains-a-hold-on-wesco-international-wcc-blurbs",
            "author": "TipRanks Auto-Generated Intelligence Newsdesk",
            "pub_date": "2025-10-31 18:59:55",
            "source": "tipranks_others",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2569195,
            "title": "RBC Capital Sticks to Its Buy Rating for Zillow Group Class A (ZG)",
            "description": "<p></p>\n<p>According to <a href=\"https://www.tipranks.com\" target=\"_blank\" style=\"color:blue\">TipRanks</a>, Erickson is a 5-star analyst with an average return of <span style=\"color:green;font-weight:bold;\">21.6%</span> and a 56.12% success rate. Erickson covers the Communication Services sector, focusing on stocks such as Reddit Inc Class A, Zillow Group Class A, and Alphabet Class A.</p>\n<p>In addition to RBC Capital, Zillow Group Class A also received a Buy from UBS’s Chris Kuntarich in a report issued today. However, on the same day, Barclays maintained a Sell rating on Zillow Group Class A (NASDAQ: ZG).</p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2023/06/Communication-Services-1-750x406.jpg",
            "link": "https://www.tipranks.com/news/blurbs/rbc-capital-sticks-to-its-buy-rating-for-zillow-group-class-a-zg-blurbs-2",
            "author": "TipRanks Auto-Generated Intelligence Newsdesk",
            "pub_date": "2025-10-31 19:00:00",
            "source": "tipranks_others",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2569196,
            "title": "RBC Capital Keeps Their Buy Rating on Argenx Se (ARGX)",
            "description": "<p></p>\n<p>Issi covers the Healthcare sector, focusing on stocks such as Ascendis Pharma, BioMarin Pharmaceutical, and Ionis Pharmaceuticals. According to <a href=\"https://www.tipranks.com\" target=\"_blank\" style=\"color:blue\">TipRanks</a>, Issi has an average return of <span style=\"color:green;font-weight:bold;\">6.7%</span> and a 41.16% success rate on recommended stocks. </p>\n<p>The word on The Street in general, suggests a Strong Buy analyst consensus rating for Argenx Se with a $898.70 average price target, representing a 9.55% upside. In a report released today, H.C. Wainwright also maintained a Buy rating on the stock with a $915.00 price target.</p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_1096459574-750x406.jpg",
            "link": "https://www.tipranks.com/news/blurbs/rbc-capital-keeps-their-buy-rating-on-argenx-se-argx-blurbs",
            "author": "TipRanks Auto-Generated Intelligence Newsdesk",
            "pub_date": "2025-10-31 19:00:07",
            "source": "tipranks_others",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2569113,
            "title": "Atlassian’s Mixed Performance: Balancing Growth and Uncertainty with a Hold Rating",
            "description": "<p></p>\n<p>Derrick Wood’s rating is based on a combination of factors that reflect both positive and cautious elements in Atlassian’s recent performance. The company reported a revenue growth of 21% for the first quarter, which was a slight beat against expectations, largely driven by new revenue recognition benefits. However, despite this organic beat, the guidance for fiscal year 2026 remained essentially unchanged when adjusted for these dynamics, indicating a conservative outlook.<br>Additionally, while there were bright spots such as the increased adoption of <a data-autolink=\"true\" href=\"https://www.tipranks.com/compare-stocks/artificial-intelligence\">AI</a> capabilities and a higher mix-shift to Cloud, these factors also introduced greater volatility in the model. This volatility, along with the complex interplay of revenue recognition changes and cloud migration, makes it difficult to accurately assess core annual recurring revenue growth trends. As a result, Derrick Wood maintains a Hold rating, reflecting both the potential and the uncertainties in Atlassian’s financial trajectory.</p>\n<p>In another report released today, Bank of America Securities also reiterated a Hold rating on the stock with a $200.00 price target.</p>\n<p></p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_1975936445-750x406.jpg",
            "link": "https://www.tipranks.com/news/ratings/atlassians-mixed-performance-balancing-growth-and-uncertainty-with-a-hold-rating-ratings",
            "author": "TipRanks Auto-Generated Intelligence Newsdesk",
            "pub_date": "2025-10-31 18:55:49",
            "source": "tipranks_others",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2569116,
            "title": "Gilead Sciences: Strong Q3 2025 Performance and Growth Potential Justify Buy Rating",
            "description": "<p></p>\n<p>Joseph Stringer has given his Buy rating due to a combination of factors that highlight Gilead Sciences’ strong financial performance and growth potential. The company reported robust earnings for the third quarter of 2025, with product sales excluding Veklury reaching $7.07 billion, which aligns with both the firm’s and consensus estimates. This performance was primarily driven by the high demand in their core HIV franchise, particularly through products like Biktarvy and Descovy, and to a lesser extent, their Liver Disease segment.<br>Additionally, Gilead’s non-GAAP earnings per share exceeded expectations, coming in at $2.47 compared to the anticipated $2.05 and $2.13 by the firm and consensus, respectively. The company also raised its total product sales guidance for 2025, reflecting confidence in continued revenue growth, especially in the HIV sector. Upcoming developments in their HIV treatment program and potential advancements in multiple myeloma treatments are seen as significant catalysts that could further enhance the stock’s performance, supporting the Buy rating and a price target of $133.</p>\n<p>Stringer covers the Healthcare sector, focusing on stocks such as Ionis Pharmaceuticals, Gilead Sciences, and Avidity Biosciences. According to <a href=\"https://www.tipranks.com\" target=\"_blank\" style=\"color:blue\">TipRanks</a>, Stringer has an average return of <span style=\"color:green;font-weight:bold;\">18.8%</span> and a 46.09% success rate on recommended stocks. </p>\n<p>In another report released today, Wells Fargo also maintained a Buy rating on the stock with a $145.00 price target.</p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_1917115745-750x406.jpg",
            "link": "https://www.tipranks.com/news/ratings/gilead-sciences-strong-q3-2025-performance-and-growth-potential-justify-buy-rating-ratings",
            "author": "TipRanks Auto-Generated Intelligence Newsdesk",
            "pub_date": "2025-10-31 18:56:01",
            "source": "tipranks_others",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2569117,
            "title": "WPP Faces Financial Challenges: Sell Rating Issued Amidst Weak Growth and Leverage Concerns",
            "description": "<p></p>\n<p>Adrien Hilaire has given his Sell rating due to a combination of factors affecting WPP’s financial outlook. The company’s third-quarter results for 2025 were underwhelming, highlighting significant challenges. Hilaire has reduced the 2026 earnings per share forecast by 25%, driven by a weaker like-for-like growth expectation and the necessity for WPP to regain balance sheet flexibility to support investments that could foster positive growth.<br>WPP’s guidance for the fourth quarter suggests further deceleration, contrasting with the performance of its peers. The company is experiencing delayed spending from key sectors such as consumer packaged goods, automotive, and technology. Additionally, WPP’s current leverage is a concern, as it limits the company’s ability to engage in strategic mergers and acquisitions. The lack of substantial assets to monetize further complicates efforts to strengthen the balance sheet, prompting the consideration of an equity raise.</p>\n<p>According to <a href=\"https://www.tipranks.com\" target=\"_blank\" style=\"color:blue\">TipRanks</a>, Hilaire is a 3-star analyst with an average return of <span style=\"color:green;font-weight:bold;\">6.6%</span> and a 55.91% success rate. Hilaire covers the Communication Services sector, focusing on stocks such as WPP, Omnicom Group, and WPP.</p>\n<p>In another report released today, Barclays also maintained a Sell rating on the stock with a £3.25 price target.</p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2023/06/Communication-Services-2-750x406.jpg",
            "link": "https://www.tipranks.com/news/ratings/wpp-faces-financial-challenges-sell-rating-issued-amidst-weak-growth-and-leverage-concerns-ratings",
            "author": "TipRanks Auto-Generated Intelligence Newsdesk",
            "pub_date": "2025-10-31 18:56:11",
            "source": "tipranks_others",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2569118,
            "title": "Foghorn Therapeutics: Advancements in Protein Degrader Programs and Strategic Partnerships Drive Buy Rating",
            "description": "<p></p>\n<p>Andres Y. Maldonado has given his Buy rating due to a combination of factors, including Foghorn Therapeutics’ significant advancements in their selective protein degrader programs targeting ARID1B, CBP, and EP300. These programs have demonstrated potent and selective degradation of key oncogenic proteins, which are historically challenging to target due to their structural complexity. The company’s lead degraders, CBPd-171 and dEP300, have shown strong target selectivity and robust anti-tumor activity across various preclinical cancer models without causing significant side effects like thrombocytopenia.<br>Additionally, Foghorn’s strategic partnership with Lilly on the FHD-909 project and the promising preclinical results reinforce the credibility of their transition from discovery to clinical application. The ongoing development of FHD-909, particularly in combination with standard chemotherapy and other inhibitors, presents a near-term clinical catalyst. Furthermore, the potential of CBP and EP300 programs to offer medium-term opportunities and the transformative potential of the ARID1B degrader in extending synthetic lethality across a broad range of tumors contribute to the positive outlook for Foghorn Therapeutics.</p>\n<p>In another report released today, Citizens JMP also maintained a Buy rating on the stock with a $9.00 price target.</p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_1931544818-750x406.jpg",
            "link": "https://www.tipranks.com/news/ratings/foghorn-therapeutics-advancements-in-protein-degrader-programs-and-strategic-partnerships-drive-buy-rating-ratings",
            "author": "TipRanks Auto-Generated Intelligence Newsdesk",
            "pub_date": "2025-10-31 18:56:20",
            "source": "tipranks_others",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2569013,
            "title": "Buy Rating Affirmed: Travere Therapeutics Surpasses Expectations with Strong Financial Performance and Strategic Milestones",
            "description": "<p></p>\n<p>Joseph Pantginis has given his Buy rating due to a combination of factors including Travere Therapeutics’ strong financial performance and strategic milestones. The company reported a significant earnings per share (EPS) of $0.28 for the third quarter of 2025, surpassing both Pantginis’s and market expectations. This positive variance was largely due to a $40 million milestone payment from CSL Vifor, as well as higher-than-anticipated sales of FILSPARI, which generated $90.9 million in revenue.<br>Additionally, Travere Therapeutics is showing promising developments in its pipeline, with ongoing studies and upcoming data presentations for FILSPARI in IgAN and FSGS. The company is also preparing to restart enrollment for the Phase 3 HARMONY study and has expanded its SPARTAN and SPARX studies. These strategic initiatives, combined with strong cash reserves and the potential for further market expansion, underpin Pantginis’s optimistic outlook and Buy rating for Travere Therapeutics.</p>\n<p>In another report released yesterday, TD Cowen also maintained a Buy rating on the stock with a $40.00 price target.</p>\n<p></p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_1911898180-750x406.jpg",
            "link": "https://www.tipranks.com/news/ratings/buy-rating-affirmed-travere-therapeutics-surpasses-expectations-with-strong-financial-performance-and-strategic-milestones-ratings",
            "author": "TipRanks Auto-Generated Intelligence Newsdesk",
            "pub_date": "2025-10-31 18:46:04",
            "source": "tipranks_others",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2569017,
            "title": "Atlassian’s Promising Growth Amidst Transition Uncertainties: A Hold Rating Analysis",
            "description": "<p></p>\n<p>Koji Ikeda’s rating is based on a combination of factors that reflect both positive and uncertain aspects of Atlassian’s financial outlook. The company reported strong first-quarter results, with Cloud revenue and non-GAAP operating margin surpassing expectations. However, while the near-term growth appears promising, the long-term financial impacts of the accelerated Data Center end-of-life plan remain unclear.<br>Despite the potential for Cloud revenue to continue growing at a robust pace, the transition from Data Center to Cloud introduces complexities, particularly in revenue recognition and marketplace monetization. Additionally, the upcoming retirement of CFO Joe Binz adds an element of execution risk, as the new CFO will need to manage the ongoing Data Center transition. These uncertainties contribute to maintaining a Hold rating until more clarity is achieved regarding the company’s financial trajectory beyond fiscal year 2026.</p>\n<p>In another report released yesterday, TR | OpenAI – 4o also reiterated a Hold rating on the stock with a $169.00 price target.</p>\n<p></p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_264965759-750x406.jpg",
            "link": "https://www.tipranks.com/news/ratings/atlassians-promising-growth-amidst-transition-uncertainties-a-hold-rating-analysis-ratings",
            "author": "TipRanks Auto-Generated Intelligence Newsdesk",
            "pub_date": "2025-10-31 18:46:15",
            "source": "tipranks_others",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2569021,
            "title": "Ardelyx’s Strong Financial Performance and Growth Potential Drive Buy Rating",
            "description": "<p></p>\n<p>Julian Harrison has given his Buy rating due to a combination of factors that highlight Ardelyx’s strong financial performance and growth potential. The company’s third-quarter earnings for 2025 exceeded expectations, with Ibsrela and Xphozah both outperforming consensus revenue estimates. Ibsrela, in particular, showed impressive growth, with a significant increase in both quarterly and yearly revenues, driven by a rise in new prescriptions and refills.<br>Furthermore, the management’s optimistic revenue guidance for Ibsrela and Xphozah suggests continued momentum. The large market size for IBS-C treatments and the unmet needs in this area provide a substantial opportunity for Ardelyx, especially as Ibsrela remains the only non-secratagogue treatment available. Additionally, the company’s strategic developments, including the introduction of a next-generation NHE3 inhibitor and key leadership appointments, reinforce its potential for sustained growth. These factors, combined with a valuation analysis, support the Buy rating.</p>\n<p>In another report released today, H.C. Wainwright also reiterated a Buy rating on the stock with a $10.00 price target.</p>\n<p>ARDX’s price has also changed slightly  for the past six months – from $5.505 to $5.010, which is a -8.99% drop .</p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_1279492897-750x406.jpg",
            "link": "https://www.tipranks.com/news/ratings/ardelyxs-strong-financial-performance-and-growth-potential-drive-buy-rating-ratings",
            "author": "TipRanks Auto-Generated Intelligence Newsdesk",
            "pub_date": "2025-10-31 18:46:26",
            "source": "tipranks_others",
            "kind": 1,
            "language": "en"
        }
    ]
}